company background image
539523

Alkem Laboratories BSE:539523 Stock Report

Last Price

₹3.07k

Market Cap

₹367.8b

7D

2.0%

1Y

-13.0%

Updated

02 Feb, 2023

Data

Company Financials +

Alkem Laboratories Limited

BSE:539523 Stock Report

Mkt Cap: ₹367.8b

539523 Stock Overview

Alkem Laboratories Limited, a pharmaceutical company, engages in the development, manufacture, and sale of pharmaceutical and nutraceutical products in India and internationally.

539523 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth3/6
Past Performance2/6
Financial Health6/6
Dividends3/6

My Notes

New

Notes are coming soon

Alkem Laboratories Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Alkem Laboratories
Historical stock prices
Current Share Price₹3,074.60
52 Week High₹3,720.00
52 Week Low₹2,835.00
Beta0.19
1 Month Change1.55%
3 Month Change-5.54%
1 Year Change-13.05%
3 Year Change28.20%
5 Year Change41.24%
Change since IPO122.56%

Recent News & Updates

Recent updates

Shareholder Returns

539523IN PharmaceuticalsIN Market
7D2.0%-1.5%-3.9%
1Y-13.0%-8.7%-4.1%

Return vs Industry: 539523 underperformed the Indian Pharmaceuticals industry which returned -9% over the past year.

Return vs Market: 539523 underperformed the Indian Market which returned -4.5% over the past year.

Price Volatility

Is 539523's price volatile compared to industry and market?
539523 volatility
539523 Average Weekly Movement1.9%
Pharmaceuticals Industry Average Movement4.6%
Market Average Movement5.7%
10% most volatile stocks in IN Market9.0%
10% least volatile stocks in IN Market3.4%

Stable Share Price: 539523 is less volatile than 75% of Indian stocks over the past 3 months, typically moving +/- 2% a week.

Volatility Over Time: 539523's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
197316,966Sandeep Singhhttps://www.alkemlabs.com

Alkem Laboratories Limited, a pharmaceutical company, engages in the development, manufacture, and sale of pharmaceutical and nutraceutical products in India and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, dermatology, cardiac, respiratory, gastro-intestinal, central nervous system, oncology, urology, and gynaecology, as well as vitamins, minerals, and nutrients; and pain analgesic, anti-diabetic, and neurology products. It also provides pregnancy detection kits and condoms.

Alkem Laboratories Limited Fundamentals Summary

How do Alkem Laboratories's earnings and revenue compare to its market cap?
539523 fundamental statistics
Market Cap₹367.79b
Earnings (TTM)₹10.92b
Revenue (TTM)₹107.59b

33.7x

P/E Ratio

3.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
539523 income statement (TTM)
Revenue₹107.59b
Cost of Revenue₹45.31b
Gross Profit₹62.28b
Other Expenses₹51.36b
Earnings₹10.92b

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

Feb 10, 2023

Earnings per share (EPS)91.31
Gross Margin57.89%
Net Profit Margin10.15%
Debt/Equity Ratio19.6%

How did 539523 perform over the long term?

See historical performance and comparison

Dividends

1.1%

Current Dividend Yield

37%

Payout Ratio